156 related articles for article (PubMed ID: 31744778)
1. Design, synthesis and biological evaluation of substituted flavones and aurones as potential anti-influenza agents.
Chintakrindi AS; Gohil DJ; Chowdhary AS; Kanyalkar MA
Bioorg Med Chem; 2020 Jan; 28(1):115191. PubMed ID: 31744778
[TBL] [Abstract][Full Text] [Related]
2. Structure-aided drug development of potential neuraminidase inhibitors against pandemic H1N1 exploring alternate binding mechanism.
Malbari KD; Chintakrindi AS; Ganji LR; Gohil DJ; Kothari ST; Joshi MV; Kanyalkar MA
Mol Divers; 2019 Nov; 23(4):927-951. PubMed ID: 30710224
[TBL] [Abstract][Full Text] [Related]
3. 3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.
Gao L; Zu M; Wu S; Liu AL; Du GH
Bioorg Med Chem Lett; 2011 Oct; 21(19):5964-70. PubMed ID: 21843936
[TBL] [Abstract][Full Text] [Related]
4. In quest of small-molecules as potent non-competitive inhibitors against influenza.
Malbari K; Saha P; Chawla-Sarkar M; Dutta S; Rai S; Joshi M; Kanyalkar M
Bioorg Chem; 2021 Sep; 114():105139. PubMed ID: 34243071
[TBL] [Abstract][Full Text] [Related]
5. A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1.
Chintakrindi AS; Martis EA; Gohil DJ; Kothari ST; Chowdhary AS; Coutinho EC; Kanyalkar MA
Curr Comput Aided Drug Des; 2016; 12(4):272-281. PubMed ID: 27412704
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.
Xiao M; Xu L; Lin D; Lian W; Cui M; Zhang M; Yan X; Li S; Zhao J; Ye J; Liu A; Hu A
Eur J Med Chem; 2021 Mar; 213():113161. PubMed ID: 33540229
[TBL] [Abstract][Full Text] [Related]
7. In search of effective H1N1 neuraminidase inhibitor by molecular docking, antiviral evaluation and membrane interaction studies using NMR.
Malbari K; Gonsalves H; Chintakrindi A; Gohil D; Joshi M; Kothari S; Srivastava S; Chowdhary A; Kanyalkar M
Acta Virol; 2018; 62(2):179-190. PubMed ID: 29895159
[TBL] [Abstract][Full Text] [Related]
8. In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase.
Li C; Fang JS; Lian WW; Pang XC; Liu AL; Du GH
Chem Biol Drug Des; 2015 Apr; 85(4):427-38. PubMed ID: 25185493
[TBL] [Abstract][Full Text] [Related]
9. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J
Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-influenza activities of novel baicalein analogs.
Chung ST; Chien PY; Huang WH; Yao CW; Lee AR
Chem Pharm Bull (Tokyo); 2014; 62(5):415-21. PubMed ID: 24572377
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, docking, and antiviral evaluation of some novel pyrimidinone-based α-aminophosphonates as potent H1N1 and HCoV-229E inhibitors.
Hekal HA; Hammad OM; El-Brollosy NR; Salem MM; Allayeh AK
Bioorg Chem; 2024 Jun; 147():107353. PubMed ID: 38615475
[TBL] [Abstract][Full Text] [Related]
12. Bioassay of ferulic acid derivatives as influenza neuraminidase inhibitors.
Cui MY; Xiao MW; Xu LJ; Chen Y; Liu AL; Ye J; Hu AX
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900174. PubMed ID: 31657061
[TBL] [Abstract][Full Text] [Related]
13. Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs.
Dholakia D; Goyal S; Jamal S; Singh A; Das A; Grover A
BMC Bioinformatics; 2016 Dec; 17(Suppl 19):512. PubMed ID: 28155702
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of 4-alkyl-2-amino(acetamino)-6-aryl-1,3-thiazine derivatives as influenza neuraminidase inhibitors.
Li W; Xia L; Hu A; Liu A; Peng J; Tan W
Arch Pharm (Weinheim); 2013 Sep; 346(9):635-44. PubMed ID: 23926081
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Novel Pyrazole Derivatives as Potent Neuraminidase Inhibitors against Influenza H1N1 Virus.
Meng FJ; Sun T; Dong WZ; Li MH; Tuo ZZ
Arch Pharm (Weinheim); 2016 Mar; 349(3):168-74. PubMed ID: 26797880
[TBL] [Abstract][Full Text] [Related]
16. C-Methylated Flavonoids from Cleistocalyx operculatus and Their Inhibitory Effects on Novel Influenza A (H1N1) Neuraminidase.
Dao TT; Tung BT; Nguyen PH; Thuong PT; Yoo SS; Kim EH; Kim SK; Oh WK
J Nat Prod; 2010 Oct; 73(10):1636-42. PubMed ID: 20886838
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents.
Lin C; Sun C; Liu X; Zhou Y; Hussain M; Wan J; Li M; Li X; Jin R; Tu Z; Zhang J
Antiviral Res; 2016 May; 129():13-20. PubMed ID: 26802557
[TBL] [Abstract][Full Text] [Related]
18. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.
Meng L; Su Y; Yang F; Xiao S; Yin Z; Liu J; Zhong J; Zhou D; Yu F
Bioorg Med Chem; 2019 Dec; 27(23):115147. PubMed ID: 31635892
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities.
Lin CH; Chang TC; Das A; Fang MY; Hung HC; Hsu KC; Yang JM; von Itzstein M; Mong KK; Hsu TA; Lin CC
Org Biomol Chem; 2013 Jun; 11(24):3943-8. PubMed ID: 23695381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
